Carbotero 150mg (Carboplatin Vials) 150mg/15ml

Carbotero 150mg is a chemotherapy medication used for cancer treatment. This 150mg/15ml vial form contains carboplatin, a platinum-based drug. It works by slowing or stopping cancer cell growth. Commonly prescribed for various cancers, it requires careful medical supervision.

Strength

150mg/15ml

Manufacturer / TM Owner

Hetero Healthcare Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carbotero 150mg is used to treat different types of cancer by interfering with cancer cell reproduction. It is often prescribed for ovarian cancer, lung cancer, and other solid tumors. Healthcare providers may also use it in combination with other chemotherapy drugs. Patients often ask, 'what is Carbotero 150mg used for' to understand its role in treatment plans.

Side Effects

Carbotero 150mg may cause side effects such as nausea, vomiting, or fatigue. Some patients experience changes in taste or hair thinning. These effects vary depending on individual health and treatment duration. Regular monitoring helps manage any discomfort during therapy.

Precautions & Warnings

Carbotero 150mg should only be handled and administered by healthcare professionals. Patients must report any unusual symptoms, such as infections or bleeding, immediately. Pregnant or breastfeeding individuals should discuss risks with their doctor. Proper storage and disposal are essential to ensure safety.

Avoid Interactions

Carbotero 150mg may interact with other medications, including certain vaccines or blood thinners. Alcohol and herbal supplements could also affect its efficacy or side effects. Patients should inform their doctor about all current medications and supplements before starting treatment.

Frequently Asked Questions

Carbotero 150mg is a chemotherapy drug used to treat various cancers, including ovarian and lung cancer.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects include nausea, vomiting, fatigue, and changes in taste or hair thinning.

Pregnant individuals should consult their doctor before using Carbotero 150mg due to potential risks.

Store vials at room temperature, away from moisture and direct light, and keep out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.